Bruce Cohen

Bruce Cohen is a Venture Partner with Xeraya Capital. Prior to joining Xeraya, Mr. Cohen was the founding President and CEO Acacia Biosciences (acquired by Rosetta Inpharmatics), Cellerant Therapeutics and VitaPath Genetics. He previously served as CFO at GeneSoft Pharmaceuticals and held senior positions at SEQUUS Pharmaceuticals and Baxter. He holds a BA and an MA from Tufts University, and an MBA with distinction from Harvard Business School.